drugset

drugset / Trial / NCT01158924

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

NCT01158924 ↗

Phase 1/2 Completed 40 enrolled DePuy Spine Janssen-Cilag Pty Ltd · collab

NaSingle-groupOpen-label

Summary

Study to show the safety, tolerability and preliminary effectiveness of Intradiscal rhGDF-5 in subjects with early lumbar disc degeneration.

Timeline

Start: 2010-03
Primary completion: 2014-03
Completion: 2014-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RADOTERMIN	Protein / enzyme biologic	—	Other

Indications